If ANY of that were accurate, BIEL would have rocked on FDA approval and stayed there - hitting a half cent or even more, and showing some holding power.
Unfortunately, BIEL performed as one would expect with billions of shareas available and zero interest from new investors: flippers churned and longs dumped, piggy-backing off the abysmal share structure to ultimately tank the price.
FACT: if share structure didn't matter, BIEL wouldn't be at .0005 today.